Literature DB >> 31396743

[Optical coherence tomography angiography for evaluation of the microcirculation in systemic diseases].

Maged Alnawaiseh1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31396743     DOI： 10.1007/s00347-019-0913-3

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  15 in total

1.  Quantitative changes in flow density in patients with adult-onset foveomacular vitelliform dystrophy: an OCT angiography study.

Authors:  Maximilian Treder; Jost Lennart Lauermann; Maged Alnawaiseh; Peter Heiduschka; Nicole Eter
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-10-03       Impact factor: 3.117

2.  [Flow density measurements using optical coherence tomography angiography : Impact of age and gender].

Authors:  M Alnawaiseh; C Brand; J L Lauermann; N Eter
Journal:  Ophthalmologe       Date:  2018-08       Impact factor: 1.059

3.  Effects of high-intensity interval training on optic nerve head and macular perfusion using optical coherence tomography angiography in healthy adults.

Authors:  Boris Schmitz; Pieter Nelis; Florian Rolfes; Maged Alnawaiseh; Andreas Klose; Michael Krüger; Nicole Eter; Stefan-Martin Brand; Florian Alten
Journal:  Atherosclerosis       Date:  2018-04-26       Impact factor: 5.162

4.  Impact of eye-tracking technology on OCT-angiography imaging quality in age-related macular degeneration.

Authors:  J L Lauermann; M Treder; P Heiduschka; C R Clemens; N Eter; F Alten
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-05-04       Impact factor: 3.117

5.  Correlation of flow density, as measured using optical coherence tomography angiography, with structural and functional parameters in glaucoma patients.

Authors:  Maged Alnawaiseh; Larissa Lahme; Viktoria Müller; André Rosentreter; Nicole Eter
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-01-13       Impact factor: 3.117

Review 6.  Optical coherence tomography angiography: A comprehensive review of current methods and clinical applications.

Authors:  Amir H Kashani; Chieh-Li Chen; Jin K Gahm; Fang Zheng; Grace M Richter; Philip J Rosenfeld; Yonggang Shi; Ruikang K Wang
Journal:  Prog Retin Eye Res       Date:  2017-07-29       Impact factor: 21.198

7.  Changes in Flow Density Measured Using Optical Coherence Tomography Angiography after iStent Insertion in Combination with Phacoemulsification in Patients with Open-Angle Glaucoma.

Authors:  Maged Alnawaiseh; Viktoria Müller; Larissa Lahme; Ralph Laurent Merté; Nicole Eter
Journal:  J Ophthalmol       Date:  2018-01-31       Impact factor: 1.909

8.  Quantification of macular perfusion using optical coherence tomography angiography: repeatability and impact of an eye-tracking system.

Authors:  Maged Alnawaiseh; Cristin Brand; Eike Bormann; Cristina Sauerland; Nicole Eter
Journal:  BMC Ophthalmol       Date:  2018-05-24       Impact factor: 2.209

9.  Feasibility of optical coherence tomography angiography to assess changes in retinal microcirculation in ovine haemorrhagic shock.

Authors:  Maged Alnawaiseh; Christian Ertmer; Laura Seidel; Philip Helge Arnemann; Larissa Lahme; Tim-Gerald Kampmeier; Sebastian Willy Rehberg; Peter Heiduschka; Nicole Eter; Michael Hessler
Journal:  Crit Care       Date:  2018-05-29       Impact factor: 9.097

10.  Aberrant ocular architecture and function in patients with Klinefelter syndrome.

Authors:  Cristin Brand; Michael Zitzmann; Nicole Eter; Sabine Kliesch; Joachim Wistuba; Maged Alnawaiseh; Peter Heiduschka
Journal:  Sci Rep       Date:  2017-10-13       Impact factor: 4.379
View more
  1 in total

1.  Ocular perfusion in patients with reduced left ventricular ejection fraction measured by optical coherence tomography angiography.

Authors:  Maged Alnawaiseh; Franziska Eckardt; Larissa Lahme; Philipp Sebastian Lange; Natasa Mihailovic; Gerrit Frommeyer; Raphael Diener; Friederike Rosenberger; Lars Eckardt; Nicole Eter
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-07-08       Impact factor: 3.117
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.